fda bans compounded semaglutide and tirzepatide Ends GLP-1s: What to Know 𝗧𝗵𝗲 𝗙𝗗𝗔 𝗶𝘀 𝗱𝗿𝗮𝘄𝗶𝗻𝗴 𝗮

Understanding what triggers lightheadedness helps you stay safe while your body adjusts to treatment

Why Pairing Low-Dose Naltrexone (LDN) With GLP-1 Therapy Could Supercharge Your Results

Tirzepatide (Zepbound), also known as Mounjaro when used for the treatment of diabetes mellitus, acts on the glucagon-like peptide-1 (GLP-1) receptor and the gastric inhibitory polypeptide to regulate appetite and food intake

Does Mounjaro cause vertigo

For the millions of women living with lipedema, a progressive disorder of connective and fat tissue characterized by disproportionate fat accumulation in the legs and arms, the treatment landscape has long been limited